US Stock MarketDetailed Quotes

SXTP 60 Degrees Pharmaceuticals

Watchlist
  • 0.591
  • -0.035-5.61%
Close Feb 14 16:00 ET
  • 0.588
  • -0.003-0.51%
Post 20:01 ET
4.09MMarket Cap-0.18P/E (TTM)

About 60 Degrees Pharmaceuticals Company

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

Company Profile

SymbolSXTP
Company Name60 Degrees Pharmaceuticals
Listing DateJul 12, 2023
Issue Price5.28
Founded2010
CEODr. Geoffrey S. Dow
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address1025 Connecticut Avenue NW,Suite 1000
CityWashington
ProvinceDistrict of Columbia
CountryUnited States of America
Zip Code20036
Phone1-202-327-5422

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Geoffrey S. Dow
  • Chief Executive Officer, President and Director
  • 125.56K
  • Kristen Landon
  • Chief Commercial Officer
  • --
  • Tyrone Miller
  • Chief Financial Officer
  • 135.63K
  • Cheryl Xu
  • Director
  • 117.83K
  • Charles W. Allen
  • Independent Director
  • 121.83K
  • Dr. Stephen Toovey
  • Independent Director
  • 120.33K
  • Paul Field
  • Independent Director
  • 120.33K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.